India’s Vaccine Regulatory System Declared Functional by WHO

India’s vaccine regulatory system has been recognized as “functional” by the World Health Organization (WHO) following an evaluation from September 16-20, 2024. The WHO assessment team confirmed that India meets global standards for ensuring vaccine safety, quality, and efficacy. This recognition reaffirms India’s significant role in the global pharmaceutical industry, especially in vaccine production, while showcasing its regulatory strength through Maturity Level 3 certification in the WHO Global Benchmarking Tool.

WHO Evaluation Overview

The WHO team evaluated key areas such as registration, licensing, market surveillance, regulatory inspections, and clinical trial oversight. India’s National Regulatory Authority (NRA), led by the Central Drugs Standard Control Organisation (CDSCO), was found to meet the required standards for a well-functioning vaccine regulatory system. The WHO Prequalification Programme underscores the importance of a robust NRA for global vaccine distribution.

Continuous Improvement and Global Role

While India’s regulatory system has reached a high benchmark, the WHO team has proposed an Institutional Development Plan for further enhancement. Union Health Secretary Punya Salila Srivastava, WHO Representative Dr. Roderico H. Ofrin, and Drugs Controller General Dr. Rajeev Singh Raghuvanshi highlighted India’s leadership in supplying vaccines globally, reaffirming its commitment to maintaining the highest standards in vaccine production and regulation.

WHO Recognition of India’s Vaccine Regulatory System

Why in News Key Points
WHO Recognition India’s vaccine regulatory system recognized as “functional” by WHO after an evaluation in September 2024.
WHO Evaluation Overview Evaluation covered registration, licensing, market surveillance, inspections, and clinical trials. India’s National Regulatory Authority (NRA), led by CDSCO, meets global standards.
Continuous Improvement and Global Role WHO proposed an Institutional Development Plan for further enhancement. India’s leadership in global vaccine supply reaffirmed.

Piyush Shukla

Recent Posts

India and Japan Conduct JAIMEX 2026: Key Activities and Significance

The India-Japan bilateral naval exercise JAIMEX 2026 took place on the 13 th and 14…

33 minutes ago

Manu Bhaker Elected to ISSF Athletes Committee for 2026–2030 Term

Indian Shooter Manu Bhaker, who has won two Olympic medals, has been elected onto the…

49 minutes ago

India re-elected to International Telecommunication Union Council for 2027-2030 term

India has been successfully re-elected to the Council of the International Telecommunication Union (ITU) for…

2 hours ago

MS Dhoni Retires from IPL, Named CSK mentor for 2027 Season

Former India & Chennai Super Kings captain Mahendra Singh Dhoni has retired from the Indian…

2 hours ago

What is Mekedatu Dam Project? Why Karnataka Wants It and Why Tamil Nadu Opposes It

The Mekedatu Dam Project is a proposal for building a balancing reservoir and drinking water…

3 hours ago

AIIMS Delhi Performs India’s First Open Fetal Surgery to Repair Spinal Defect

Doctors at the All India Institute of Medical Sciences (AIIMS) in New Delhi have completed…

4 hours ago